SLDB logo

SLDB
Solid Biosciences Inc

6,179
Mkt Cap
$708.42M
Volume
903,445.00
52W High
$8.72
52W Low
$2.41
PE Ratio
-3.65
SLDB Fundamentals
Price
$7.38
Prev Close
$7.20
Open
$7.28
50D MA
$6.68
Beta
1.92
Avg. Volume
1.73M
EPS (Annual)
-$1.99
P/B
3.24
Rev/Employee
$0.00
$325.62
Loading...
Loading...
News
all
press releases
Solid Biosciences (NASDAQ:SLDB) Trading Down 6.7% - Here's Why
Solid Biosciences (NASDAQ:SLDB) Trading Down 6.7% - Here's Why...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
Solid Biosciences (NASDAQ:SLDB) Shares Up 5.5% After Analyst Upgrade
Solid Biosciences (NASDAQ:SLDB) Trading 5.5% Higher on Analyst Upgrade...
MarketBeat·7d ago
News Placeholder
JPMorgan Chase & Co. Raises Solid Biosciences (NASDAQ:SLDB) Price Target to $12.00
JPMorgan Chase & Co. lifted their price objective on shares of Solid Biosciences from $11.00 to $12.00 and gave the stock an "overweight" rating in a research report on Wednesday...
MarketBeat·8d ago
News Placeholder
Solid Biosciences (NASDAQ:SLDB) Earns "Buy" Rating from HC Wainwright
HC Wainwright reaffirmed a "buy" rating and set a $20.00 target price on shares of Solid Biosciences in a research note on Monday...
MarketBeat·10d ago
News Placeholder
Solid Biosciences Inc. (NASDAQ:SLDB) Given Consensus Rating of "Moderate Buy" by Brokerages
Solid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) has received an average recommendation of "Moderate Buy" from the twelve research firms that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation and eleve...
MarketBeat·10d ago
News Placeholder
Solid Biosciences (NASDAQ:SLDB) Shares Gap Up - What's Next?
Solid Biosciences (NASDAQ:SLDB) Shares Gap Up - Time to Buy...
MarketBeat·13d ago
News Placeholder
Guggenheim Initiates Coverage on Solid Biosciences (NASDAQ:SLDB)
Guggenheim started coverage on shares of Solid Biosciences in a research note on Friday. They set a "buy" rating and a $26.00 price target on the stock...
MarketBeat·13d ago
News Placeholder
Solid Biosciences (NASDAQ:SLDB) Earns "Buy" Rating from Chardan Capital
Chardan Capital restated a "buy" rating and set a $15.00 price objective on shares of Solid Biosciences in a research note on Friday...
MarketBeat·13d ago
News Placeholder
Solid Biosciences (NASDAQ:SLDB) Given "Buy" Rating at Needham & Company LLC
Needham & Company LLC reiterated a "buy" rating and issued a $19.00 target price on shares of Solid Biosciences in a research note on Friday...
MarketBeat·13d ago
News Placeholder
Solid Biosciences (NASDAQ:SLDB) Issues Earnings Results
Solid Biosciences (NASDAQ:SLDB - Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.53) EPS for the quarter, missing the consensus estimate of ($0.48) by ($0.05...
MarketBeat·13d ago
<
1
2
...
>

Latest SLDB News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.